Abstract
Dr. Stiehm's review article in Pediatrics (63:301, 1979) is excellent in its comprehensive treatment of the use of immune serum globulin. However, the portion on Rh immune globulin (RhIG) has two omissions regarding current management of the Rh-negative woman: (1) Amniocentesis is an indication for considering the use of RhIG in the Rh-negative pregnant woman, and (2) evidence of massive fetal-maternal hemorrhage (placenta abruptio, placenta previa, or neonatal anemia) in the Rh-negative woman should be cause for an attempt to determine the magnitude of that bleed and gauge the dose of RhIG to the volume of that bleed.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
